Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaohui Meng

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
Arthritis & Rheumatology (Hoboken, N.J.)|December 22, 2025
Plasma Proteomics Identifies TAOK3 as a Potential Biomarker of Rheumatoid Arthritis Activity and a Novel Therapeutic TargetPengfei Xin, Wenzhen Li, Xinyu A, et al.
Journal of Immunology Research|August 12, 2022
Expanded CD1c<sup>+</sup>CD163<sup>+</sup> DC3 Population in Synovial Tissues Is Associated with Disease Progression of OsteoarthritisGuowei Qiu, Sheng Zhong, Jun Xie, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 16, 2023
Role and Therapeutic Potential for Targeting Fibroblast Growth Factor 10/FGFR1 in Relapsed Rheumatoid ArthritisXiaohui Meng, Zechuan Chen, Teng Li, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
Arthritis & Rheumatology (Hoboken, N.J.)|December 22, 2025
Plasma Proteomics Identifies TAOK3 as a Potential Biomarker of Rheumatoid Arthritis Activity and a Novel Therapeutic TargetPengfei Xin, Wenzhen Li, Xinyu A, et al.
Journal of Immunology Research|August 12, 2022
Expanded CD1c<sup>+</sup>CD163<sup>+</sup> DC3 Population in Synovial Tissues Is Associated with Disease Progression of OsteoarthritisGuowei Qiu, Sheng Zhong, Jun Xie, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 16, 2023
Role and Therapeutic Potential for Targeting Fibroblast Growth Factor 10/FGFR1 in Relapsed Rheumatoid ArthritisXiaohui Meng, Zechuan Chen, Teng Li, et al.
Pageof 5